Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Lundgren

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Expert Review of Vaccines|May 4, 2012
Recent progress toward an enterotoxigenic Escherichia coli vaccineAnn-Mari Svennerholm, Anna Lundgren
FEMS Immunology and Medical Microbiology|April 20, 2007
Progress in vaccine development against Helicobacter pyloriAnn-Mari Svennerholm, Anna Lundgren
Current Opinion in Immunology|July 31, 2023
Developments in oral enterotoxigenic Escherichia coli vaccinesAnn-Mari Svennerholm, Anna Lundgren
Vaccine|May 19, 2009
Parallel analysis of mucosally derived B- and T-cell responses to an oral typhoid vaccine using simplified methodsAnna Lundgren, Joanna Kaim, Marianne Jertborn
Vaccine|May 3, 2016
Induction of long term mucosal immunological memory in humans by an oral inactivated multivalent enterotoxigenic Escherichia coli vaccineAnna Lundgren, Marianne Jertborn, Ann-Mari Svennerholm
Vaccine|May 14, 2013
Different kinetics of circulating antibody-secreting cell responses after primary and booster oral immunizations: a tool for assessing immunological memorySusannah Leach, Anna Lundgren, Ann-Mari Svennerholm
Plos One|January 4, 2013
The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigensSusannah Leach, John D Clements, Joanna Kaim, et al.
Vaccine|November 10, 2019
Booster vaccination with a fractional dose of an oral cholera vaccine induces comparable vaccine-specific antibody avidity as a full dose: A randomised clinical trialLynda Mottram, Anna Lundgren, Ann-Mari Svennerholm, et al.
Frontiers in Immunology|April 8, 2021
A Systems Biology Approach Identifies B Cell Maturation Antigen (BCMA) as a Biomarker Reflecting Oral Vaccine Induced IgA Antibody Responses in HumansLynda Mottram, Anna Lundgren, Ann-Mari Svennerholm, et al.
Vaccine|October 20, 2009
CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementationTanvir Ahmed, Mohammad Arifuzzaman, Michael Lebens, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Expert Review of Vaccines|May 4, 2012
Recent progress toward an enterotoxigenic Escherichia coli vaccineAnn-Mari Svennerholm, Anna Lundgren
FEMS Immunology and Medical Microbiology|April 20, 2007
Progress in vaccine development against Helicobacter pyloriAnn-Mari Svennerholm, Anna Lundgren
Current Opinion in Immunology|July 31, 2023
Developments in oral enterotoxigenic Escherichia coli vaccinesAnn-Mari Svennerholm, Anna Lundgren
Vaccine|May 19, 2009
Parallel analysis of mucosally derived B- and T-cell responses to an oral typhoid vaccine using simplified methodsAnna Lundgren, Joanna Kaim, Marianne Jertborn
Vaccine|May 3, 2016
Induction of long term mucosal immunological memory in humans by an oral inactivated multivalent enterotoxigenic Escherichia coli vaccineAnna Lundgren, Marianne Jertborn, Ann-Mari Svennerholm
Vaccine|May 14, 2013
Different kinetics of circulating antibody-secreting cell responses after primary and booster oral immunizations: a tool for assessing immunological memorySusannah Leach, Anna Lundgren, Ann-Mari Svennerholm
Plos One|January 4, 2013
The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigensSusannah Leach, John D Clements, Joanna Kaim, et al.
Vaccine|November 10, 2019
Booster vaccination with a fractional dose of an oral cholera vaccine induces comparable vaccine-specific antibody avidity as a full dose: A randomised clinical trialLynda Mottram, Anna Lundgren, Ann-Mari Svennerholm, et al.
Frontiers in Immunology|April 8, 2021
A Systems Biology Approach Identifies B Cell Maturation Antigen (BCMA) as a Biomarker Reflecting Oral Vaccine Induced IgA Antibody Responses in HumansLynda Mottram, Anna Lundgren, Ann-Mari Svennerholm, et al.
Vaccine|October 20, 2009
CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementationTanvir Ahmed, Mohammad Arifuzzaman, Michael Lebens, et al.
Pageof 7